Revitocrine

Business Services · California, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

600 W Broadway Ste 1200, San Diego, Cali...

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Revitocrine

Revitocrine is a research-based biopharmaceutical company dedicated to discovering therapies for patients with liver and gastrointestinal (GI) diseases. Their advanced research focuses on the farnesoid X receptor (FXR), which plays a crucial role in modulating these diseases. The company has made significant progress in identifying and characterizing distinct chemical entities aimed at developing innovative therapeutic candidates. Revitocrine's approach includes structure-guided drug discovery and a proprietary library of novel fragments to facilitate the identification of valuable lead candidates.Explore more
Popular SearchesRevitocrineSIC Code 87,873NAICS Code 54,541Show more

Is Revitocrine your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Revitocrine

Compare insights from companies similar to Revitocrine, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Revitocrine

<$5M
11-50
Private
-
-
N/A
<$5M
11-50
Private
-
-
N/A
<$5M
11-50
Private
-
2020
N/A
<$5M
1-10
Private
-
-
N/A
<$5M
1-10
Private
-
-
N/A
<$5M
1-10
Private
-
2013
N/A
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Revitocrine is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Revitocrine is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Revitocrine.

Top Business Services Companies

Frequently Asked Questions Regarding Revitocrine

What is Revitocrine's official website?
Revitocrine's official website is www.revitocrine.com
What is Revitocrine's Revenue?
Revitocrine's revenue is <$5 Million
What is Revitocrine's SIC code?
Revitocrine's SIC: 87,873
What is Revitocrine's NAICS code?
Revitocrine's NAICS: 54,541
How many employees does Revitocrine have?
Revitocrine has 11-50 employees
What industry does Revitocrine belong to?
Revitocrine is in the industry of: Business Services, Research & Development
What is Revitocrine competition?
Revitocrine top competitors include: Nash Aware, Knowtro, Marc Perez (Sole Proprietorship, UCLA Connection Lab
What does Revitocrine do?

Revitocrine is a research-based biopharmaceutical company dedicated to discovering therapies for patients with liver and gastrointestinal (GI) diseases. Their advanced research focuses on the farnesoid X receptor (FXR), which plays a crucial role in modulating these diseases. The company has made significant progress in identifying and characterizi... ng distinct chemical entities aimed at developing innovative therapeutic candidates. Revitocrine's approach includes structure-guided drug discovery and a proprietary library of novel fragments to facilitate the identification of valuable lead candidates.Read More

Is Revitocrine a public company?
Revitocrine is private company therefore does not currently have an official ticker symbol
See more information about Revitocrine

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.